![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 31, 23927-23932, August 4, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Physiology, The Johns Hopkins University
School of Medicine, Baltimore Maryland 21205
Received for publication, March 28, 2000, and in revised form, April 27, 2000
Thirty-five mutations were generated in the yeast
secretory pathway/Golgi ion pump, Pmr1, targeting oxygen-containing
side chains within the predicted transmembrane segments M4, M5, M6, M7,
and M8, likely to be involved in coordination of Ca2+
and Mn2+ ions. Mutants were expressed in low copy number in
a yeast strain devoid of endogenous Ca2+ pumps and screened
for loss of Ca2+ and Mn2+ transport on the
basis of hypersensitivity to
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) and Mn2+ toxicity, respectively. Three classes
of mutants were found: mutants indistinguishable from wild type (Class
1), mutants indistinguishable from the pmr1 null strain
(Class 2), and mutants with differential sensitivity to BAPTA and
Mn2+ toxicity (Class 3). We show that Class 1 mutants
retain normal/near normal properties, including 45Ca
transport, Golgi localization, and polypeptide conformation. In
contrast, Class 2 mutants lacked any detectable 45Ca
transport; of these, a subset also showed defects in trafficking and
protein folding, indicative of structural problems. Two residues identified as Class 2 mutants in this screen, Asn774 and
Asp778 in M6, also play critical roles in related ion pumps
and are therefore likely to be common architectural components of the cation-binding site. Class 3 mutants appear to have altered selectivity for Ca2+ and Mn2+ ions, as exemplified by
mutant Q783A in M6. These results demonstrate the utility of phenotypic
screening in the identification of residues critical for ion transport
and selectivity in cation pumps.
Ion pumps belonging to the family of P-type ATPases occur in all
cells, where they drive transmembrane ion gradients of up to
10,000-fold (reviewed in Ref. 1). Well known members of the family
include the Na+/K+-ATPase of animal cells,
H+/ATPase of fungi and plants, and various
Ca2+-ATPases found in plasma membrane and endomembrane
compartments. Individual pumps have evolved distinct cation
selectivities to fulfill a variety of different physiological functions
including Ca2+ homeostasis, acid (H+)
extrusion, generation of Na+ and K+
electrochemical gradients, and the detoxification of soft metals (Cu2+, Cd2+, and Zn2+). Despite
their differences in cation selectivity, [P]ATPases share many
structural and mechanistic similarites. Remarkably, the electron
micrograph structures (8 Å) of the fungal H+-ATPase and
the sarcoplasmic reticulum Ca2+-ATPase are virtually
superimposable within the dimensions of the membrane (2, 3). In both
cases, densities corresponding to ten transmembrane helices are clearly
visible, of which three are clustered to enclose a well defined pore,
plausibly the pathway for ion translocation, extending from the
cytoplasmic to the lumenal/extracellular space. A variety of
experimental evidence points to three helices, transmembrane segments
M4, M5, and M6, that are most likely to be involved in transport. For
example, in the sarcoplasmic reticulum Ca2+-ATPase,
mutagenesis of residues in M4, M5, and M6 prevent cation binding and
inactivate transport (reviewed in Ref. 4), and cysteine residues
engineered into M4 and M6 can be disulfide-linked (5). The proximity of
M5 and M6 may be inferred from studies on the fungal
H+-ATPase showing the presence of a salt bridge between
residues in these two helices (6).
Defining the residues that compose the ion-binding site(s) is a first
step toward understanding how vectorial transport occurs. Extensive
mutagenesis studies have contributed to the emerging molecular picture
of the transport site in which oxygen-containing side chains coordinate
one or more cations. Thus, in SERCA, residues Glu309 (M4),
Glu771 (M5), and Asn796, Thr799,
and Asp800 (M6), are required for binding two
Ca2+ ions (reviewed in Ref. 4). Similar studies in the
Na+/K+-ATPase have revealed the important role
of residues Ser775 (M5), Asp804, and
Asp808 (M6) in K+ and possibly Na+,
binding (reviewed in Ref. 7). Interestingly, Asn796 and
Asp800 of SERCA occupy equivalent positions to
Asp804 and Asp808 in
Na+/K+-ATPase, suggesting that the architecture
of the ion-binding site may be similar in the two enzymes. Additional
studies on other ion pumps will be key to determining whether this
similarity extends throughout the family.
The [P]ATPases offer a striking paradigm for the evolutionary
development of ion selectivity; yet the molecular basis for selectivity
remains one of the fundamental unanswered questions in the field. From
studies on other classes of transport proteins, it is clear that
selectivity is determined by the local environment around key residues
(8, 9). However, it is difficult to identify, from conventional
site-directed mutagenesis alone, which residues are important for
distinguishing between different ions, such as Ca2+ and
Na+. Despite having completely nonoverlapping ion
selectivities, four of five residues important for Ca2+
binding in SERCA are conserved in equivalent positions in the Na+/K+-ATPase sequence so that these residues
cannot be considered to define ion selectivity.
Here we report on the mutagenesis of every oxygen-containing side chain
within membrane segments M4-M8 of Pmr1, the yeast secretory
pathway/Golgi ion pump. Previous studies from our lab (10, 11), as well
as others (12-14), have suggested that Pmr1 mediates the high affinity
transport of Ca2+ and Mn2+ into the secretory
pathway for a variety of secretory functions, including protein
sorting, processing, and glycosylation. A novel aspect of this study is
the phenotypic screening of yeast mutants to identify residues that are
critical for Ca2+ and Mn2+ transport and
selectivity. We show that this approach greatly simplifies the analysis
of mutants and can be used to screen large numbers of mutants in future
random mutagenesis studies. We expect that this approach can be
extended to the study of heterologous ion pumps expressed in yeast,
including Ca2+-ATPases from animal and plant systems (15,
16).
Media, Strains, and Growth Assays--
Yeast strains were grown
in defined media containing yeast nitrogen base (6.7 g/liter; Difco),
dextrose (2%), and supplements as needed. PMR1-containing
plasmids were introduced into strain K616 (17), which carries null
alleles of calcineurin B (CNB1) and two
Ca2+-ATPases (PMR1 and PMC1),
resulting in low basal Ca2+ pump activity, as described
previously (10). Growth assays were performed by inoculating 100 µl
of YNB medium in a 96-well plate with 2-5 µl of a saturated seed
culture followed by incubation for 48 h at 30 °C. Where
indicated, MnCl2 or
BAPTA1 was added to the
medium prior to inoculation, and the pH was adjusted to 6.0 with NaOH.
Cultures were thoroughly mixed by gentle vortexing, and growth was
monitored by measuring absorbance at 600 nm in a SPECTRAmax 340 microplate reader (Molecular Devices). Relative growth was expressed as
the fraction of the absorbance of the control culture (no additions).
Plasmids and Mutagenesis--
YEpHR1, a yeast 2µ plasmid
carrying the PMR1 coding sequence under control of a tandem
repeat of a yeast heat shock element has been described previously
(10). YCpHR1 is an identical construct made in a single
copy/CEN backbone derived from plasmid YCplac33 (18). Amino
acid substitutions were introduced into an
EcoRI-PstI fragment or a
HindIII-EcoRI fragment of PMR1
subcloned into the bacterial vector pBlueScript (Stratagene) using the
inverse polymerase chain reaction reaction (19) and a pair of
oligonucleotide primers in each case. The PMR1 fragment was
entirely sequenced to rule out unwanted mutations. Reconstruction of
the mutagenized fragments into plasmids YEpHR1 and YCpHR1 was by
standard cloning techniques.
Cell Fractionation and Biochemical Methods--
Preparations of
total membranes, subcellular fractionation by sucrose gradient
centrifugation, and isolation of Golgi vesicles from yeast were exactly
as described earlier (10). Protein concentration was determined by a
modified Lowry assay (20) following precipitation of samples containing
sucrose with 10% trichloroacetic acid and using bovine serum albumin
as standard. Samples were prepared for electrophoresis by precipitating
with trichloroacetic acid as described (10). SDS-PAGE and
Western blotting using polyclonal antibody raised against the
C-terminal one-third of Pmr1 were performed as described previously
(10).
45Ca2+ Transport
Assays--
ATP-dependent 45Ca transport
assays of sucrose gradient fractions and pooled Golgi membranes were
done by rapid filtration as described previously (10). Concanamycin A
(Sigma; 10 nM) and carbonyl cyanide
p-chlorophenylhydrazone (25 µM) were
added to eliminate activity of vacuolar H+/Ca2+
exchange. In assays of Mn2+ competition, 45Ca
was at 0.4 µCi/ml (nominally, 0.8 µM), and
MnCl2 was added as indicated.
Trypsinolysis--
Preparations of total membranes (1 mg/ml)
were treated with trypsin (TosPheCH2Cl-treated,
Sigma) at a trypsin to protein ratio of 1:10 in buffer containing 20 mM Tris-HCl, pH 7.0, 0.1 M KCl, and 5 mM MgCl2. When specified, samples were
preincubated for 5 min with Na2ATP (pH 6.7) added to a
final concentration of 5 mM. After 5 min at 30 °C, the
digests were terminated by addition of trichloroacetic acid to 10%.
Samples were chilled on ice (30 min) and collected by
microcentrifugation (30 min), and the resulting pellets were
resuspended in gel loading buffer for electrophoresis.
Three Classes of pmr1 Mutants Are Revealed by Phenotypic Screening
of BAPTA and Mn2+ Toxicity--
Mutant yeast strains
lacking a functional copy of Pmr1, a P-type ATPase found in the Golgi,
exhibit distinct Ca2+ and Mn2+-related cellular
defects (12-14). Hypersensitivity of pmr1 mutants to
depletion of extracellular Ca2+ or Mn2+, by
chelating agents such as BAPTA or EGTA, appears to be due to a
lack of high affinity transport of these ions into the secretory pathway, where they serve essential functions in protein sorting, glycosylation, and secretion. It has been shown that BAPTA toxicity may
be overcome by the introduction of minimal free concentrations of
either Ca2+ (~0.84 nM) or Mn2+
(~0.16 pM) to growth media (14), indicating that the two
ions can play largely surrogate roles in supporting yeast growth.
Because standard yeast media have nearly a 100-fold excess of
Ca2+ relative to Mn2+, and the latter is
efficiently removed at low chelator concentrations, the observed growth
inhibition by BAPTA in pmr1 mutants represents a titration
of the remaining Ca2+. Hypersensitivity of pmr1
mutants to Mn2+ toxicity is a specific consequence of loss
of Mn2+ transport. Although essential for growth, excess
Mn2+ is toxic and must be removed by delivery into the
secretory pathway by Pmr1 and subsequent exit from the cell. Thus, we
reasoned that sensitivity to BAPTA and Mn2+ toxicity would
be a preliminary indication of the Ca2+ and
Mn2+ transporting activity of Pmr1 mutants.
35 mutations were made at potential cation-binding sites (Asp,
Glu, Asn, Gln, Ser, Thr, and Tyr) in the predicted transmembrane segments M4, M5, M6, M7, and M8 of Pmr1. Residues were substituted with
Ala, and in the case of acidic residues, also as follows: Asp
Mutants fell into one of three classes, as exemplified in Fig.
1. Class 1 mutants, such as mutant T826A,
were indistinguishable from wild type in both BAPTA and
Mn2+ tolerance assays and were assumed to have largely
normal transport function. Class 2 mutants, such as mutant D778A,
displayed a null phenotype for both BAPTA and Mn2+
tolerance, suggesting a complete loss of function. Interestingly, some
mutants displayed differential tolerance to BAPTA and Mn2+
and were grouped as Class 3 mutants. An extreme example is mutant Q783A
(Fig. 1), in which tolerance to BAPTA is at wild type levels, whereas
tolerance to Mn2+ is similar to the null mutant, suggesting
that Ca2+ transport is retained but Mn2+
transport is lost. Two other mutants (E329A and A749D) showed intermediate profiles of BAPTA tolerance but complete loss of Mn2+ tolerance. These are putative ion selectivity
mutants.
A complete classification of all 35 mutants reported in this study is
listed in Table I. None of the residues
targeted for mutagenesis in membrane segments M4 and M8 were found to
be essential for function; although the apparently conservative
substitutions E329D (M4) and D856E (M8) were Class 2 (loss-of-function)
mutants, substitution with Ala restored function either partially
(E329A) or completely (D856A). Alanine substitutions of residues
Gln742 (M5), Asn774 and Asp778
(M6), and Thr817 (M7) resulted in loss-of-function
phenotypes. Additional substitution of Asp778 with Glu and
Asn also failed to restore function, confirming the importance of this
residue in cation transport.
Biogenesis, Targeting, and Ion Transport Characteristics of pmr1
Mutants--
As the first step in a systematic biochemical analysis of
mutants, we checked expression levels in rapid, small scale, total membrane preparations of yeast transformants, following heat
shock-induced expression from multicopy (2µ) plasmids (10). Western
blots using anti-Pmr1 polyclonal antibody provided evidence for the biogenesis and membrane insertion of all mutant Pmr1 proteins, albeit
with some variation in expression levels, as shown in the samples in
Fig. 2. Curiously, Class 2 mutants N774A,
D778E, T817A, and D856E had distinctly faster mobility on SDS-PAGE
(Figs. 2 and 4). Mutant plasmids were rescued from the transformed
yeast strains and analyzed by restriction enzyme mapping and DNA
sequencing to confirm the integrity of the mutant gene (not shown). The
faster mobility appeared not to be related to altered glycosylation or phosphorylation of the
protein2 and was tentatively
assumed to be a first indication of abnormal conformation.
Trafficking of mutant Pmr1 proteins was examined on well defined
sucrose density gradient fractionations of yeast lysates. This analysis
was essential to normalize ion transport activity to Pmr1 expression
levels in the Golgi fractions and can be considered a second indication
of structural problems, because incorrectly folded ATPases are retained
and subsequently degraded in the yeast endoplasmic reticulum (21). Fig.
3 shows the subcellular localization of a
subset of Pmr1 mutants; a complete listing of organellar localization
is found in Table I. We have previously demonstrated a clear separation
of the lighter Golgi fractions (fractions 4-6 in Fig. 3) from
endoplasmic reticulum, the latter being distributed in the denser half
of the sucrose gradient (fractions 8-11). All of the Class 1 mutants
showed normal trafficking to the Golgi, consistent with their normal
phenotype. Among the other two classes of mutants, some displayed
normal trafficking, as depicted in Fig. 3 for D778N. Others were
retained in the endoplasmic reticulum, either partially (A749D) or
completely (D778E). When the target residue was acidic
(Asp778 and Asp856), there was a striking
difference in targeting depending upon the nature of the substitution.
Surprisingly, substitution with another acidic residue (Asp
Individual fractions of the sucrose gradient were assayed for
45Ca transport activity. As described earlier, the host
strain was essentially devoid of endogenous Ca2+ pump
activity, whereas plasmid-encoded Pmr1 transport activity was largely
restricted to Golgi membrane containing fractions. All Class 1 mutants
had significant transport activity ranging from ~10 to 150% of wild
type levels as depicted for mutant N859A in Fig. 3. In contrast, Class
2 mutants had no detectable transport activity above the
vector-transformed control (mutants E329D, D778N, and D778E in Fig. 3).
Of the putative ion selectivity mutants (Class 3), Q783A had wild type
levels of Ca2+ transport activity (not shown), whereas
mutants A749D and E329A (Fig. 3) were reduced to 10 and 30% of wild
type, respectively.
Limited Proteolysis as a Probe of Polypeptide Folding--
An
important step in mutant analysis is the assessment of the structural
integrity of mutant polypeptides. We have previously described the use
of limited proteolysis as a probe of overall protein conformation (11).
Golgi membranes were treated with trypsin in the presence or absence of
ATP to detect ligand-induced conformational changes, and mutants were
screened for specific proteolytic intermediates, as illustrated in the
examples shown in Fig. 4. An
ATP-protectable 52-kDa tryptic fragment was detected in all mutants
with normal Golgi trafficking, similar to that seen in the wild type
protein (Fig. 4; E329D, N859A, and D778N). Interestingly, there was a
progressive loss of ATP-protection with increasing defects in
localization; thus, in mutants showing partial ER retention, ATP
protection against trypsinolysis was poor, whereas mutants showing
complete ER retention had no ATP-protectable fragments (Fig. 4; N774A,
D778E, and D856E). Table I lists the efficiency of ATP protection
against proteolysis for all mutants in this study.
Manganese Inhibition of Calcium Transport Is a Measure of
Mn2+ Selectivity--
We have observed saturable
54Mn uptake into Golgi vesicles isolated from strains
expressing wild type Pmr1 but not from the null mutant
K616,3 consistent with the
proposed role of Pmr1 in Mn2+ transport. An alternative
approach is to use Mn2+ inhibition of 45Ca
transport to assess Mn2+ transport activity, as reported
earlier (11). Here, we examine the effectiveness of Mn2+
inhibition in the putative ion selectivity (Class 3) mutant Q783A. Fig.
5 shows that Mn2+ is a potent
inhibitor of 45Ca transport in Golgi vesicles containing
wild type Pmr1, with half-maximal inhibition occurring at 0.2 µM, under conditions where the Ca2+
concentration is nominally 0.8 µM (approximately 10-fold
in excess over the Km for Ca2+; Refs.
10, and 11). These data suggest that ion selectivity of wild type Pmr1
is Mn2+ > Ca2+. In contrast, half-maximal
inhibition for the Q783A mutant ocurred at 12 µM, a
60-fold shift relative to wild type. These results are consistent with
a dramatic reduction in the affinity for Mn2+, and
consequently hypersensitivity to Mn2+ toxicity (Fig. 1), in
this mutant.
In this study, we describe an effective strategy to screen for
amino acid residues critical for ion transport and selectivity in yeast
mutants of the secretory pathway/Golgi ion pump, Pmr1. As a test of
this approach, we used alanine-scanning site-directed mutagenesis of
acidic and polar residues within the transmembrane segments most likely
to constitute the translocation pore. Mutants were readily classified
in one of three groups based upon cell growth in BAPTA- or
Mn2+-supplemented medium. Class 1 mutants did not display
hypersensitivity to either BAPTA or Mn2+, a first
indication of normal function. Further analysis confirmed that these
mutants showed normal trafficking to the Golgi, had significant
45Ca transport activity and appeared to be correctly folded
based upon the ability of ATP to protect against trypsinolysis. Most of
the residues targeted for mutagenesis in this study fell into this
class (Fig. 6) and were not essential for
pump function, as was observed in previous site-directed mutagenesis
studies of this scale on the Na+/K+-ATPase,
H+-ATPase, and SERCA (reviewed in Refs. 4, 7, and 22).
Class 2 mutants were hypersensitive to both BAPTA and Mn2+
toxicity, indicative of a complete lack of pump function, which was confirmed by the lack of 45Ca transport activity in
isolated Golgi fractions. To distinguish between structural and
functional derangements, we analyzed protein trafficking and
sensitivity to trypsinolysis. Mutants that showed normal Golgi
trafficking also displayed ATP-protectable trypsin fragments, whereas
those that showed ER retention failed to generate ATP-protectable
tryptic peptides. The latter also displayed increased mobility upon gel
electrophoresis, for reasons that are currently unresolved. These
observations are consistent with abnormal polypeptide folding and
indicate sites that are sensitive to structural perturbations. Unexpectedly, Asp Fig. 6 summarizes the results of our study. None of the target residues
in transmembrane segments M4 or M8 were essential for function,
although substitution-specific loss of function was observed at
Glu329 and Asp856. Structural and trafficking
defects were also seen with alanine substitution of Gln742
(M5), Asn774 (M6), and Thr817 (M7), resulting
in complete loss of function. However, alanine and asparagine
substitution mutants of Asp778 (M6) showed normal
trafficking and polypeptide conformation yet lacked transport activity,
making this residue a good candidate for the cation-binding pocket.
Strikingly similar findings have been reported for mutations at
residues equivalent to Asn774 and Asp778 of the
plasma membrane Ca2+-ATPase: thus, mutant N879A was
retained in endoplasmic reticulum, whereas mutant D883A showed normal
trafficking to the plasma membrane (23). Both showed a complete loss of
Ca2+ transport activity (23, 24). Alanine substitutions of
the equivalent residues in the Na+/K+-ATPase,
Asp804 and Asp808, however, do not prevent
trafficking to the plasma membrane, as judged by ouabain binding
ability in intact cells (7), but are also associated with loss of
transport activity. Thus, these two sites appear to be common
components of the cation-binding site in most P-type ATPases. One
exception is the fungal H+-ATPase, Pma1, where
Asp730 (equivalent to Asp778 of Pmr1) forms a
salt bridge with Arg695 in M5; simultaneous substitution of
both residues with alanine does not alter function (6).
The simple growth screens based on BAPTA and Mn2+ toxicity
in pmr1 mutants are capable of distinguishing between
essential and nonessential residues and can be used to screen large
numbers of randomly generated mutants in future studies. We also show that the screens can identify potential sites of cation selectivity. Three such sites were identified in this study; in each case, the
mutants showed greater sensitivity to Mn2+ toxicity than to
that of the Ca2+ chelator BAPTA in growth assays,
suggesting that the mutation had a more deleterious effect on
Mn2+ transport. However, in a previous study, we have
reported on a mutation with the converse effect; D53A, within the
N-terminal modulatory EF hand-like domain in Pmr1, was
indistinguishable from wild type in the Mn2+ toxicity assay
(11), but BAPTA toxicity in this mutant was intermediate between wild
type and the pmr1 null mutant.3 We showed that
apparent Mn2+ affinity was slightly increased relative to
wild type, whereas there was a 11-fold reduction in Ca2+
transport affinity in this mutant (11). Here, we show that Q783A has
normal Ca2+ transport but a 60-fold reduction in the
apparent affinity for Mn2+. Only one such mutation with a
similar dramatic effect on ion selectivity has been reported in studies
on other ion pumps; substitution of Ser775 in M5 with
alanine in the Na+/K+-ATPase causes a 30-fold
decrease in only K+ but not Na+ affinity (25,
26).
It is worth noting that only two of five residues required for
Ca2+ binding in SERCA were essential in Pmr1. A likely
interpretation is that unlike SERCA, which has a stoichiometry of two
Ca2+ transported per ATP, Pmr1 transports only one cation
transported per ATP. In the sequence of Pmr1 and its homologues, Ala
and Met occupy positions equivalent to Glu771 (M5) and
Thr799 (M6) of SERCA, consistent with a fewer number of
cation-binding sites. These differences support the classification of
the newly emergent secretory pathway Ca2+-ATPases as a
group distinct from but related to the well known endoplasmic reticulum pumps.
*
This work was supported by American Cancer Society Grants
IRG11-33 and JFRA 538, American Heart Association Grant-in-aid
95012290, and National Institutes of Health Grant GM52414 (to R. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, May 5, 2000, DOI 10.1074/jbc.M002618200
2
D. M. Mandal and R. Rao, unpublished results.
3
Y. Wei and R. Rao, unpublished results.
The abbreviations used are:
BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid;
PAGE, polyacrylamide gel electrophoresis;
SERCA, sarco/endoplasmic reticulum Ca2+-ATPase;
ER, endoplasmic
reticulum.
Phenotypic Screening of Mutations in Pmr1, the Yeast Secretory
Pathway Ca2+/Mn2+-ATPase, Reveals Residues
Critical for Ion Selectivity and Transport*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Asn,
Glu and Glu
Asp, Gln. In one case, an Asp was introduced to replace
Ala749 in M5 so as to mimic the sequence of the SERCA pump.
Pmr1 mutants were introduced into the yeast strain K616
(
pmr1
pmc1
cnb1), which we have previously shown
to be devoid of endogenous Ca2+ pump activity (10). To
ensure low level expression of the pump for phenotype analysis, mutants
were expressed under control of the heat shock element, from single
copy/CEN plasmids, and grown at 30 °C. We found that in
the absence of heat shock, leak-through expression of Pmr1 was similar
to native levels of expression from the endogenous promoter (not
shown). Each mutant was screened for sensitivity to BAPTA and
Mn2+ in quantitative liquid growth assays, as described
under "Experimental Procedures." Plasmids containing wild type
PMR1 (YCpHR1) and the empty vector (YCpH2) were also
transformed into strain K616 as controls.

View larger version (16K):
[in a new window]
Fig. 1.
Representative examples of three classes of
pmr1 mutants. Host strain K616
(
pmr1
pmc1
cnb1) was
transformed with a low copy vector (YCpH1) carrying either wild type
PMR1 (WT) or mutants T826A, D778A, and Q783A.
Cells were grown in YNB medium supplemented with BAPTA (A)
or Mn2+ (B) as indicated for 48 h at
30 °C. Growth (A600) was normalized to
control (no additions). T826A was representative of Class 1 mutants and
resembled the wild type in both growth assays. D778A, a Class 2 mutant,
displayed a hypersensitivity to growth inhibition by BAPTA and
Mn2+, similar to the null strain (vector). The
Class 3 mutant Q783A had differential sensitivity to BAPTA and
Mn2+, suggestive of a change in ion selectivity.
, WT;
, vector;
, T826A-Class 1;
, D778A-Class 2;
, Q783A-Class 3.
Summary of pmr1 mutant phenotype, targeting, and protein folding

View larger version (14K):
[in a new window]
Fig. 2.
Western blot of yeast total membranes showing
expression levels of mutant Pmr1 ATPases. Wild type
(WT), host strain K616 (
pmr1), and
a representative set of mutants are indicated. 20 µg of protein was
loaded in each lane, and the blot was probed with anti-Pmr1 polyclonal
antibody. Note the faster mobility of mutants N774A, D778E, and D856E
also apparent in Fig. 4.
Glu and
Glu
Asp) led to ER retention and concomitant loss of function
(Table I), whereas substitution with a neutral residue allowed correct
Golgi targeting. Another interesting finding from this study was that
complete ER retention consistently correlated with faster mobility of
the mutant Pmr1 polypeptide upon SDS gel electrophoresis, possibly
indicating an abnormal protein conformation that was resistant to
unfolding in SDS. It should be noted that mutants showing ER retention
continued to show trafficking problems under normal culture
temperatures of 30 °C, which obviate the possibly deleterious
effects of heat shock-induced expression (at 37 °C) on protein
targeting.

View larger version (29K):
[in a new window]
Fig. 3.
Trafficking and Ca2+ transport
activity of Pmr1 ATPases in subcellular fractions. Fractions from
sucrose density gradients of yeast lysates were analyzed for
45Ca transport activity (A) and Pmr1 expression
on Western blots (B) as described in the the legend to Fig.
2. Mutants with high (N859A), partial (E329A), and no detectable
activity (E329D, D778N, and D778E) are shown. Note the difference in
localization between Golgi (wild type, E329A, E329D, D778N, and N859A)
and endoplasmic reticulum (D778E).

View larger version (49K):
[in a new window]
Fig. 4.
Limited trypsinolysis as a conformational
probe of Pmr1 ATPases. Yeast total membranes were treated with
trypsin and subjected to Western analysis, as described under
"Experimental Procedures." Where indicated, membranes were
preincubated with 5 mM ATP. The presence of an
ATP-protectable 52-kDa tryptic fragment (asterisk) in
mutants E329D, N859A, and D778N correlates with Golgi localization and
normal mobility of Pmr1 polypeptides on SDS-PAGE, as shown in Figs. 2
and 3 and Table I. Conversely, the absence of this fragment in mutants
N774A, D778E, and D856E correlates with abnormal mobility and
localization.

View larger version (15K):
[in a new window]
Fig. 5.
Manganese inhibition of 45Ca
transport. 45Ca uptake into purified Golgi vesicles
was assayed in the presence of added Mn2+, as indicated.
45Ca was fixed at 0.8 µM in the absence of
chelators. The data points are averages of duplicate determinations,
and the line is a best fit of the equation v = Vmax·I/(K0.5 + I),
where I is the Mn2+ concentration and
v is the measured rate of 45Ca transport.
Derived values of K0.5 for wild type Pmr1
(WT) and mutant Q783A are in the text.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (25K):
[in a new window]
Fig. 6.
Summary of mutants. Transmembrane
segments M4-M8 are depicted as
-helices, and residues targeted for
mutagenesis in this study are color-coded based on the resulting
phenotype (see text). When multiple substitutions were made, the effect
of the least deleterious substitution is represented. The Class 2 mutants depicted in bold type showed structural and
trafficking defects.
Glu and Glu
Asp substitutions caused
structural problems, whereas replacement with the neutral alanine did
not. Although the perturbation caused by introduction of the longer glutamate side chain may be rationalized as a steric effect, it is not
clear why substitution of aspartate, a shorter carboxylate side chain,
in place of glutamate was more deleterious than that of alanine. One
possibility is that within the confines of the membrane, differences in
dihedral angle preferences for the carboxyl group of aspartate and
glutamate may be important.
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Physiology,
Johns Hopkins University School of Medicine, 725 N. Wolfe St.,
Baltimore MD 21205. Tel.: 410-955-4732; Fax: 410-955-0461; E-mail:
rrao@jhmi.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Moller, J. V.,
Juul, B.,
and le Maire, M.
(1996)
Biochim. Biophys. Acta
1286,
1-51
2.
Zhang, P.,
Toyoshima, C.,
Yonekura, K.,
Green, N. M.,
and Stokes, D. L.
(1998)
Nature
392,
835-839
3.
Auer, M.,
Scarborough, G. A.,
and Kuhlbrandt, W.
(1998)
Nature
392,
840-843
4.
MacLennan, D. H.,
Rice, W. J.,
and Odermatt, A.
(1997)
Ann. N. Y. Acad. Sci.
834,
175-185
5.
Rice, W. J.,
Green, N. M.,
and MacLennan, D. H.
(1997)
J. Biol. Chem.
272,
31412-31419
6.
Sen Gupta, S.,
DeWitt, N. D.,
Allen, K. E.,
and Slayman, C. W.
(1998)
J. Biol. Chem.
273,
34328-34334
7.
Lingrel, J. B.,
Croyle, M. L.,
Woo, A. L.,
and Arguello, J. M.
(1998)
Acta Physiol. Scand.
163,
69-77
8.
Hama, H.,
and Wilson, T. H.
(1994)
J. Biol. Chem.
269,
1063-1067
9.
Galzi, J.-L.,
Devillers-Thiery, A.,
Hussy, N.,
Bertrand, S.,
Changeux, J.-P.,
and Bertrand, D.
(1992)
Nature
359,
500-505
10.
Sorin, A.,
Rosas, G.,
and Rao, R.
(1997)
J. Biol. Chem.
272,
9895-9901
11.
Wei, Y.,
Marchi, V.,
Wang, R.,
and Rao, R.
(1999)
Biochemistry
38,
14534-14541
12.
Antebi, A.,
and Fink, G. R.
(1992)
Mol. Biol. Cell
3,
633-654
13.
Lapinskas, P. J.,
Cunningham, K. W.,
Liu, X. F.,
Fink, G. R.,
and Culotta, V. C.
(1995)
Mol. Cell. Biol.
15,
1382-1388
14.
Durr, G.,
Strayle, J.,
Plemper, R.,
Elbs, S.,
Klee, S. K.,
Catty, P.,
Wolf, D.,
and Rudolph, H. K.
(1998)
Mol. Biol. Cell
9,
1149-1162
15.
Liang, F.,
Cunningham, K. W.,
Harper, J. F.,
and Sze, H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8579-8584
16.
Degand, I.,
Catty, P.,
Talla, E.,
Thines-Sempoux, D.,
d'Exaerde, A.,
Goffeau, A.,
and Ghislain, M.
(1999)
Mol. Microbiol.
31,
545-556
17.
Cunningham, K. W.,
and Fink, G. R.
(1994)
J. Cell Biol.
124,
351-363
18.
Gietz, R. D.,
and Sugino, A.
(1988)
Gene (Amst.)
74,
527-534
19.
Fisher, C. L.,
and Pei, G. K.
(1997)
BioTechniques
23,
570-574
20.
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275
21.
Nakamoto, R. K.,
Verjovski-Almeida, S.,
Allen, K. E.,
Ambesi, A.,
Rao, R.,
and Slayman, C. W.
(1998)
J. Biol. Chem.
273,
7338-7344
22.
Ambesi, A.,
DeWitt, N. D.,
Petrov, V. V.,
Sen Gupta, S.,
and Slayman, C. W.
(1998)
Acta Physiol. Scand. Suppl.
643,
107-113
23.
Guerini, D.,
Foletti, D.,
Vellani, F.,
and Carafoli, E.
(1996)
Biochemistry
35,
3290-3296
24.
Adebayo, A. O.,
Enyedi, A.,
Verma, A. K.,
Filoteo, A. G.,
and Penniston, J. T.
(1995)
J. Biol. Chem.
270,
27812-27816
25.
Blostein, R.,
Wilczynska, A.,
Karlish, S. J. D.,
Arguello, J. M.,
and Lingrel, J. B
(1997)
J. Biol. Chem.
272,
24987-24993
26.
Pedersen, P. A.,
Nielsen, J. M.,
Rasmussen, J. H.,
and Jorgensen, P. L.
(1998)
Biochemistry
37,
17818-17827
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Devasahayam, D. J. Burke, and T. W. Sturgill Golgi Manganese Transport Is Required for Rapamycin Signaling in Saccharomyces cerevisiae Genetics, September 1, 2007; 177(1): 231 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dode, J. P. Andersen, L. Raeymaekers, L. Missiaen, B. Vilsen, and F. Wuytack Functional Comparison between Secretory Pathway Ca2+/Mn2+-ATPase (SPCA) 1 and Sarcoplasmic Reticulum Ca2+-ATPase (SERCA) 1 Isoforms by Steady-state and Transient Kinetic Analyses J. Biol. Chem., November 25, 2005; 280(47): 39124 - 39134. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. C. Culotta, M. Yang, and M. D. Hall Manganese Transport and Trafficking: Lessons Learned from Saccharomyces cerevisiae Eukaryot. Cell, July 1, 2005; 4(7): 1159 - 1165. [Full Text] [PDF] |
||||
![]() |
M. Xiang, D. Mohamalawari, and R. Rao A Novel Isoform of the Secretory Pathway Ca2+,Mn2+-ATPase, hSPCA2, Has Unusual Properties and Is Expressed in the Brain J. Biol. Chem., March 25, 2005; 280(12): 11608 - 11614. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.-K. Ton and R. Rao Functional expression of heterologous proteins in yeast: insights into Ca2+ signaling and Ca2+-transporting ATPases Am J Physiol Cell Physiol, September 1, 2004; 287(3): C580 - C589. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mandal, S. J. Rulli, and R. Rao Packing Interactions between Transmembrane Helices Alter Ion Selectivity of the Yeast Golgi Ca2+/Mn2+-ATPase PMR1 J. Biol. Chem., September 12, 2003; 278(37): 35292 - 35298. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gupta, V.-K. Ton, V. Beaudry, S. Rulli, K. Cunningham, and R. Rao Antifungal Activity of Amiodarone Is Mediated by Disruption of Calcium Homeostasis J. Biol. Chem., August 1, 2003; 278(31): 28831 - 28839. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Fairclough, L. Dode, J. Vanoevelen, J. P. Andersen, L. Missiaen, L. Raeymaekers, F. Wuytack, and A. Hovnanian Effect of Hailey-Hailey Disease Mutations on the Function of a New Variant of Human Secretory Pathway Ca2+/Mn2+-ATPase (hSPCA1) J. Biol. Chem., June 27, 2003; 278(27): 24721 - 24730. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Delhaize, T. Kataoka, D. M. Hebb, R. G. White, and P. R. Ryan Genes Encoding Proteins of the Cation Diffusion Facilitator Family That Confer Manganese Tolerance PLANT CELL, May 1, 2003; 15(5): 1131 - 1142. [Abstract] [Full Text] |
||||
![]() |
T. Shigaki, J. K. Pittman, and K. D. Hirschi Manganese Specificity Determinants in the Arabidopsis Metal/H+ Antiporter CAX2 J. Biol. Chem., February 14, 2003; 278(8): 6610 - 6617. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Cronin, R. Rao, and R. Y. Hampton Cod1p/Spf1p is a P-type ATPase involved in ER function and Ca2+ homeostasis J. Cell Biol., June 10, 2002; 157(6): 1017 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.-K. Ton, D. Mandal, C. Vahadji, and R. Rao Functional Expression in Yeast of the Human Secretory Pathway Ca2+, Mn2+-ATPase Defective in Hailey-Hailey Disease J. Biol. Chem., February 15, 2002; 277(8): 6422 - 6427. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shigaki, N.-h. Cheng, J. K. Pittman, and K. Hirschi Structural Determinants of Ca2+ Transport in the Arabidopsis H+/Ca2+ Antiporter CAX1 J. Biol. Chem., November 9, 2001; 276(46): 43152 - 43159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Engelse, J. M Neele, A. L.J.J Bronckers, H. Pannekoek, and C. J.M de Vries Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor {alpha}-1 and the protective factor matrix gla protein in human atherogenesis Cardiovasc Res, November 1, 2001; 52(2): 281 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mandal, T. B. Woolf, and R. Rao Manganese Selectivity of Pmr1, the Yeast Secretory Pathway Ion Pump, Is Defined by Residue Gln783 in Transmembrane Segment 6. RESIDUE Asp778 IS ESSENTIAL FOR CATION TRANSPORT J. Biol. Chem., July 28, 2000; 275(31): 23933 - 23938. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Van Baelen, J. Vanoevelen, L. Missiaen, L. Raeymaekers, and F. Wuytack The Golgi PMR1 P-type ATPase of Caenorhabditis elegans. IDENTIFICATION OF THE GENE AND DEMONSTRATION OF CALCIUM AND MANGANESE TRANSPORT J. Biol. Chem., March 30, 2001; 276(14): 10683 - 10691. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||